Guidelines: 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure – Question #27 With Dr. Randall Starling
By CardioNerds - Last Updated: November 16, 2023The CardioNerds correspondents Akiva Rosenzveig and Dr. Ahmed Ghoneem are joined by expert faculty Dr. Randall Starling, of the Cleveland Clinic, to analyze the following question, which refers to Section 7.2 of the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure.
| Which of the following sentences regarding the use of diuretics in the management of heart failure (HF) is correct? | |
| A | In patients with HF who have minimal congestive symptoms, medical management with diuretics alone is sufficient to improve outcomes. |
| B | Prescribing a loop diuretic on discharge after hospitalization for HF may improve short-term mortality and HF rehospitalization rates. |
| C | The combination of thiazide (or thiazide-like) diuretics with loop diuretics is preferred to higher doses of loop diuretics in patients with HF and congestive symptoms. |
| D | The maximum daily dose of furosemide is 300 mg. |
Listen to the episode to hear the interesting perspectives the panel had to share.
The Decipher the Guidelines: 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure series was developed by The CardioNerds and created in collaboration with the American Heart Association and the Heart Failure Society of America. It was produced by 30 trainees—spanning the education spectrum from college through advanced fellowship—under the leadership of The CardioNerds co-founders, Drs. Amit Goyal and Dan Ambinder, with mentorship from Drs. Anu Lala, Robert Mentz, and Nancy Sweitzer. Thanks to Drs. Judy Bezanson and Elliott Antman for their tremendous guidance.
This podcast originally appeared on The CardioNerds.
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.